Computational drug discovery of potential phosphodiesterase inhibitors using in silico studies

Asian Pacific Journal of Tropical Disease

Volumn 2, Issue SUPPL2, 2012, Pages

  Madeswaran, Arumugam ^a   Umamaheswari, Muthuswamy ^a   Asokkumar, Kuppusamy ^a   Sivashanmugam, Thirumalaisamy ^a   Subhadradevi, Varadharajan ^a   Jagannath, Puliyath ^a  

^a Sri Ramakrishna Institute of Paramedical Sciences   (India)

Author keywords

Binding energy; Inhibition constant; Intermolecular energy

Indexed keywords

AROMADEDRIN; BIOCHANIN A; CAFFEINE; ERIODICTYOL; ISORHAMNETIN; OKANIN; PHOSPHODIESTERASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; BINDING ENERGY; BINDING SITE; COMPUTER MODEL; DRUG POTENCY; ENZYME BINDING; GENETIC ALGORITHM; INHIBITION ENERGY; INTERMOLECULAR ENERGY; MOLECULAR DOCKING; PRIORITY JOURNAL;

EID: 84871769985     PISSN: 22221808     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2222-1808(12)60272-2     Document Type: Article

References (23)

1. Cavasotto CN, Abagyan RA Protein flexibility in ligand docking and virtual screening to protein kinases. J. Mol. Biol 2004, 12:209-225.
2. Schoichet BK Virtual screening of chemical libraries. Nature 2004, 43:862-865.
3. Koppen H Virtual screening - what does it give us?. Curr. Opin. Drug Disc. Dev 2009, 12:397-407.
4. Collignon B, Schulz R, Smith JC Task-parallel message passing interface implementation of Autodock4 for docking of very large databases of compounds using high-performance super-computers. J. Comput. Chem 2011, 32:1202-1209.
5. Schames JR, Henchman RH, Seigel JS, Sotriffer CA, Ni H, Mccammon A Discovery of a Novel Binding Trench in HIV Integrase. J. Med. Chem 2004, 47:1879-1881.
6. Cosconati S, Forli S, Perryman AL, Harris R, Goodsell DS, Olson A Virtual Screening with AutoDock: Theory and Practice. J. Exp. Opin. Drug Disc 2010, 5:597-607.
7. Seeliger D, Groot BL Ligand docking and binding site analysis with PyMOL and Autodock/Vina. J. Comput. Aided Mol. Des 2010, 24:417-424.
8. Middleton EJ Effect of plant flavonoids on immune and inflammatory cell function. Adv Exp Med Biol 1998, 439:175-182.
9. Groot H, Rauen U Tissue injury by reactive oxygen species and the protective effects of flavonoids. Fundam Clin Pharmacol 1998, 12:249-255.
10. Formica JV, Regelson W Review of the biology of quercetin and related bioflavonoids. Food Chem Toxicol 1995, 33:1061-1080.
11. Zhang HT, Zhao Y, Huang Y, Dorairaj NR, Chandler LJ, Donnell JM Inhibition of the phosphodiesterase 4 (PDE4) enzyme reverses memory deficits produced by infusion of the MEK inhibitor U0126 into the CA1 subregion of the rat hippocampus. Neuropsychopharmacology 2004, 29(8):1432-1439.
12. Jeon Y, Heo Y, Kim C, Hyun Y, Lee T, Ro S, Cho J Phosphodiesterase: overview of protein structures, potential therapeutic applications and recent progress in drug development. Cell Mol Life Sci 2005, 62(11):1198-1220.
13. Wang C Phosphodiesterase-5 inhibitors and benign prostatic hyperplasia. Curr. Opin. Urol 2010, 20(1):49-54.
14. Fertel R, Weiss B Properties and drug responsiveness of cyclic nucleotide phosphodiesterases of rat lung. Mol. Pharmacol 1976, 12:678-687.
15. Strada SJ, Uzunov P, Weiss B Ontogenetic development of a phosphodiesterase activator and the multiple forms of cyclic AMP phosphodiesterase of rat brain. J. Neurochem 1974, 23:1097-1103.
16. Khairallah M, Khairallah RJ, Young ME Sildenafil and cardiomyocyte-specific cGMP signaling prevent cardiomyopathic changes associated with dystrophin deficiency. Proc. Nat. Acad. Sci 2008, 105(19):7028-7033.
17. Khodade P, Prabhu R, Chandra N Parallel implementation of Autodock. J App Crystal 2007, 40:598-599.
18. Konc J, Konc JT, Penca M, Janezic M Binding-sites prediction assisting protein-protein docking. Acta Chim. Solv 2011, 58:396-401.
19. Umamaheswari M, Madeswaran A, Asokkumar K, Sivashanmugam T, Subhadradevi V, Jagannath P Study of potential xanthine oxidase inhibitors: In silico and in vitro biological activity biological activity biological activity biological activity. Bangladesh J Pharmacol 2011, 6:117-123.
20. Chang MW, Ayeni C, Breuer S Virtual screening for HIV protease inhibitors: A comparison of AutoDock 4 and vina. PLOS ONE 2010, 5:119-155.
21. Park H, Lee J, Lee S Critical assessment of the automated AutoDock as a new docking tool for virtual screening. Proteins 2006, 65:549-554.
22. Madeswaran A, Umamaheswari M, Asokkumar K, Sivashanmugam T, Subhadradevi V, Jagannath P In Silico docking studies of lipoxygenase inhibitory activity of commercially available flavonoids. J. Comput. Method. Mol. Design 2011, 1:65-72.
23. Umamaheswari M, Madeswaran A, Asokkumar K, Sivashanmugam T, Subhadradevi V, Jagannath P Discovery of potential xanthine oxidase inhibitors using in silico docking studies. Der Pharma Chemica 2011, 3:240-247.